Who
We Are
01Vision
02Mission
I am privileged to lead a company that stands at the forefront of the international biopharmaceutical landscape.
BioGeneric Pharma S.A.E, under our collective vision and unwavering commitment, has become a beacon of excellence in the development and production & marketing of therapeutic recombinant antibodies ,proteins and vaccines.
Professor Dr. Mohamed Rabie Sayed, Msc. FMRC, PhD
President and Chief Executive Officer
BioGeneric Pharma Company
Let’s discuss your project with Our BGP team
BGP is focusing on the development and marketing of high quality and cost-effective “off Patent” biosimilars through local manufacturing in BGP’s facility in Egypt targeting EMEA & FDA markets as well as to cover local needs, Africa and Middle East.
BGP is gradually developing a network of local and regional collaborative partners for sales and marketing of its products.
The aim is to use this network enabling launch of the product candidates over time. It is critical for BGP to establish partners that have strong local presence and can realize the full sales potential of the respective products in their market.
BGP is an international company for development, manufacturing, analysis and marketing of Biopharmaceutical products.
